Last €51.27 EUR
Change Today +0.76 / 1.51%
Volume 30.0
CRE On Other Exchanges
Symbol
Exchange
CRE is not on other exchanges.
As of 1:17 PM 11/21/14 All times are local (Market data is delayed by at least 15 minutes).

cerner corp (CRE) Snapshot

Open
€50.52
Previous Close
€50.51
Day High
€51.39
Day Low
€50.50
52 Week High
11/14/14 - €52.00
52 Week Low
04/28/14 - €34.90
Market Cap
17.5B
Average Volume 10 Days
487.7
EPS TTM
--
Shares Outstanding
341.5M
EX-Date
--
P/E TM
--
Dividend
--
Dividend Yield
--
Current Stock Chart for CERNER CORP (CRE)

cerner corp (CRE) Related Businessweek News

View More BusinessWeek News

cerner corp (CRE) Details

Cerner Corporation designs, develops, markets, installs, hosts, and supports healthcare information technology, healthcare devices, hardware, and content solutions for healthcare organizations and consumers worldwide. It offers the Cerner Millennium architecture, which combines clinical, financial, and management information systems that allows providers to access an individual’s electronic health record (EHR) at the point of care, and organizes and delivers information for physicians, nurses, laboratory technicians, pharmacists, front and back-office professionals, and consumers. The company also provides the Healthe Intent platform, a cloud-based architectural platform for population health that is agnostic to the source EHR and captures research, evidence, and financial and operational data, as well as provides the ability to apply statistical algorithms against contextual clinical activity to recommend clinical action. In addition, it offers a range of services, including implementation and training, remote hosting, operational management services, revenue cycle services, support and maintenance, healthcare data analysis, clinical process optimization, transaction processing, employer health centers, employee wellness programs, and third party administrator services for employer-based health plans. The company serves integrated delivery networks, physician groups and networks, managed care organizations, hospitals, medical centers, reference laboratories, home health agencies, blood banks, imaging centers, pharmacies, pharmaceutical manufacturers, employers, governments, and public health organizations. Cerner Corporation was founded in 1979 and is headquartered in North Kansas City, Missouri.

14,200 Employees
Last Reported Date: 02/5/14
Founded in 1979

cerner corp (CRE) Top Compensated Officers

Co-Founder, Chairman and Chief Executive Offi...
Total Annual Compensation: $1.0M
President
Total Annual Compensation: $510.0K
Chief Financial Officer, Executive Vice Presi...
Total Annual Compensation: $471.5K
Chief Operating Officer and Executive Vice Pr...
Total Annual Compensation: $565.4K
Chief of Staff and Executive Vice President
Total Annual Compensation: $565.4K
Compensation as of Fiscal Year 2013.

cerner corp (CRE) Key Developments

Cerner Corporation to Present Comprehensive Preventive Care Solutions at Cerner Health Conference

Cerner Corporation announced it will present its Preventive Care Advisor solution during the Cerner Health Conference in Kansas City. The solution delivers real-time lists of eligible Medicare-approved preventive screenings, which can help improve care and overall patient wellness. Another solution to be presented at CHC is Cerner Virtual Patient Observer, a proprietary overseer system to monitor high fall risk and behavioral patients. It utilizes Microsoft's Kinect sensor system to detect risky patient movement in a hospital or home environment. With Cerner Virtual Patient Observer, a nurse technician can monitor multiple patient rooms from one central monitoring station and quickly intervene. Scott Leftwich and Cerner Senior Director Caleb Anderson will present the Preventive Care Advisor(TM) solution on Nov. 5, at CHC, which runs Nov. 2-5. Cerner's Virtual Patient Observer(TM) solution for fall prevention will also be demonstrated.

Truven Health Analytics Announces Agreement with Cerner Corporation to Resell its Micromedex(R) Carenotes(R) Product

Truven Health Analytics announced an agreement with Cerner Corporation to resell its Micromedex(R) CareNotes(R) product, a part of the Patient Connect Suite of patient and consumer education and engagement solutions. The evidence-based, health literacy standardized resources in CareNotes will be accessible directly from Cerner's EHR by clinicians in Acute Care and Ambulatory facilities and will include resources for the Emergency Department, Inpatient Discharge Instructions, General Health Summaries, Pre-care, Inpatient, Laboratory and Medication Education, among other tools and content, in multiple languages. The addition of CareNotes allows clinicians using Cerner solutions in virtually any care setting to seamlessly access, from within Cerner applications, trusted, evidence-based Micromedex CareNotes patient education resources. CareNotes can be used by provider organizations for Meaningful Use (MU) attestation as requirements evolve; and the integrated access helps clinicians increase efficiency, adoption, and use of relevant, meaningful education for patients and family members. CareNotes patient departure instructions and education documents are written at a 5th to 7th grade reading comprehension level that helps to reach Joint Commission and Meaningful Use (MU) standards, and include: CareNotes-Concise patient-handouts and discharge instructions covering disease, condition, treatment and procedure for pre- and post-treatment patient care, self-care, diet, and exercise topics-for every venue of care. Medication Instructions-Concise patient-handouts on the most commonly prescribed medications to guide patients on how to take their medications, what to avoid while taking these medications, precautions to be aware of, and possible side effects. Consumer Lab Education-Concise patient-handouts to help patients understand procedures for frequently performed tests, including lab descriptions, results interpretation, risks, and descriptions of how the test is done, including how it will feel, and what follow-up is necessary.

Cerner Corporation Announces Unaudited Consolidated Earnings Results for the Third Quarter and Nine Months Ended September 27, 2014; Provides Earnings Guidance for the Fourth Quarter and Full Year of 2014 and for Fiscal Year 2015

Cerner Corporation announced unaudited consolidated earnings results for the third quarter and nine months ended September 27, 2014. For the quarter, the company reported revenue of $840.1 million an increase of 15% compared to $727.8 million in the year-ago period. Adjusted net earnings for third quarter 2014 were $145.3 million, compared to $123.6 million of adjusted net earnings in the third quarter of 2013. Adjusted diluted earnings per share were $0.42 in the third quarter of 2014, an increase of 20% compared to $0.35 of adjusted diluted earnings per share in the year-ago quarter. GAAP net earnings were $129 million or $0.37 per diluted share against third quarter 2013 GAAP net earnings of $115.3 million and diluted earnings per share were $0.33. Operating cash flow was $220 million. Capital expenditures were $68 million. Free cash flow, defined as operating cash flow less capital expenditures and capitalized software, was $107 million. Operating earnings were $188,154,000 against $169,238,000 for the same period in the last year. Earnings before income taxes were $190,335,000 against $172,747,000 for the same period in the last year. For the nine months, total revenues were $2,476,672,000 against $2,115,420,000 for the same period in the last year. Operating earnings were $557,790,000 against $492,263,000 for the same period in the last year. Earnings before income taxes were $565,698,000 against $501,549,000 for the same period in the last year. Net earnings were $377,561,000 or $1.08 per diluted share against $338,291,000 or $0.96 per diluted share for the same period in the last year. Adjusted diluted earnings per share were $1.18 against $1.02 for the same period in the last year. Cash flows from operating activities (GAAP) were $623,579,000 against $554,385,000 for the same period in the last year. Capital purchases were $200,372,000 against $218,406,000 for the same period in the last year. Free cash flow (non-GAAP) was $292,446,000 against $210,028,000 for the same period in the last year. The company provided earnings guidance for the fourth quarter and full year of 2014 and for fiscal year 2015. For the quarter, the company expects revenue of $880 million to $915 million and adjusted EPS is seen at $0.46 to $0.47. The company expects tax rate to be between 33% and 34%. The company expects capital expenditures to be $260 million to $280 million for the year, which is down from $353 million in 2013. For the year 2015, the company expects adjusted EPS to be in a range of $2.05 to $2.15 when include estimated accretion from the acquisition. For revenue, the company expects a combined revenue of $4.8 billion to $5 billion.

 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
CRE:GR €51.27 EUR +0.76

CRE Competitors

Market data is delayed at least 15 minutes.

Company Last Change
CR Bard Inc $166.50 USD -0.61
Edwards Lifesciences Corp $123.50 USD -1.89
Fidelity National Information Services Inc $59.90 USD +0.20
Intuitive Surgical Inc $515.43 USD +1.91
Zimmer Holdings Inc $110.48 USD +0.36
View Industry Companies
 

Industry Analysis

CRE

Industry Average

Valuation CRE Industry Range
Price/Earnings 50.8x
Price/Sales 6.8x
Price/Book 6.4x
Price/Cash Flow 49.4x
TEV/Sales 6.3x
 | 

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact CERNER CORP, please visit www.cerner.com. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.